Cargando…

Paraoxonase 1 gene (PON1) variants concerning hepatitis C virus (HCV) spontaneous clearance in hemodialysis individuals: a case–control study

BACKGROUND: To explore associations between PON1 rs854560, rs662, 705,379, HCV clearance, and interactions between tested PON1 single nucleotide variants (SNVs) and interferon-λ4 gene (IFNL4) rs368234815 variant in hemodialyzed individuals. METHODS: The study included 83 HD individuals who spontaneo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grzegorzewska, Alicja E., Mostowska, Adrianna, Warchoł, Wojciech, Jagodziński, Paweł P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394142/ https://www.ncbi.nlm.nih.gov/pubmed/34445971 http://dx.doi.org/10.1186/s12879-021-06597-4

Ejemplares similares

Paraoxonase 1 gene variants concerning cardiovascular mortality in conventional cigarette smokers and non-smokers treated with hemodialysis
por: Grzegorzewska, Alicja E., et al.
Publicado: (2021)

Paraoxonase 1 concerning dyslipidaemia, cardiovascular diseases, and mortality in haemodialysis patients
por: Grzegorzewska, Alicja E., et al.
Publicado: (2021)

Polymorphisms of T helper cell cytokine-associated genes and survival of hemodialysis patients – a prospective study
por: Grzegorzewska, Alicja E., et al.
Publicado: (2017)

Polymorphisms of Vitamin D Signaling Pathway Genes and Calcium-Sensing Receptor Gene in respect to Survival of Hemodialysis Patients: A Prospective Observational Study
por: Grzegorzewska, Alicja E., et al.
Publicado: (2016)

Circulating Interferon-λ3, Responsiveness to HBV Vaccination, and HBV/HCV Infections in Haemodialysis Patients
por: Grzegorzewska, Alicja E., et al.
Publicado: (2017)

Polymorphism rs368234815 of interferon lambda 4 gene and spontaneous clearance of hepatitis C virus in haemodialysis patients: a case-control study
por: Grzegorzewska, Alicja E., et al.
Publicado: (2021)

Calcium-sensing receptor gene (CASR) polymorphisms and CASR transcript level concerning dyslipidemia in hemodialysis patients: a cross-sectional study
por: Grzegorzewska, Alicja E., et al.
Publicado: (2019)

Antibodies to hepatitis B virus surface antigen and interleukin 12 and interleukin 18 gene polymorphisms in hemodialysis patients
por: Grzegorzewska, Alicja E, et al.
Publicado: (2012)

Energy Homeostasis Gene Nucleotide Variants and Survival of Hemodialysis Patients—A Genetic Cohort Study
por: Świderska, Monika Katarzyna, et al.
Publicado: (2022)

Association of the interleukin-12 polymorphic variants with the development of antibodies to surface antigen of hepatitis B virus in hemodialysis patients in response to vaccination or infection
por: Grzegorzewska, Alicja E., et al.
Publicado: (2013)

Associations of the calcium-sensing receptor gene CASR rs7652589 SNP with nephrolithiasis and secondary hyperparathyroidism in haemodialysis patients
por: Grzegorzewska, Alicja E., et al.
Publicado: (2016)

ENHO, RXRA, and LXRA polymorphisms and dyslipidaemia, related comorbidities and survival in haemodialysis patients
por: Grzegorzewska, Alicja E., et al.
Publicado: (2018)

T-Cell Cytokine Gene Polymorphisms and Vitamin D Pathway Gene Polymorphisms in End-Stage Renal Disease due to Type 2 Diabetes Mellitus Nephropathy: Comparisons with Health Status and Other Main Causes of End-Stage Renal Disease
por: Grzegorzewska, Alicja E., et al.
Publicado: (2014)

Serum paraoxonase 1 (PON1) measurement: an update
por: Ceron, Jose J, et al.
Publicado: (2014)

Alzheimer’s Disease and Paraoxonase 1 (PON1) Gene Polymorphisms
por: Saeidi, Mohsen, et al.
Publicado: (2017)

Paraoxonases (PON) 1, 2, and 3 Polymorphisms and PON-1 Activities in Patients with Sickle Cell Disease
por: Reichert, Cadiele Oliana, et al.
Publicado: (2019)

Paraoxonase (PON1 and PON3) Polymorphisms: Impact on Liver Expression and Atorvastatin-Lactone Hydrolysis
por: Riedmaier, Stephan, et al.
Publicado: (2011)

Paraoxonase-1 (PON1) promoter region polymorphisms, serum PON1 status and coronary heart disease
por: Mackness, Bharti, et al.
Publicado: (2013)

Monocyte chemoattractant protein-1 gene (MCP-1-2518 A/G) polymorphism and serological markers of hepatitis B virus infection in hemodialysis patients
por: Grzegorzewska, Alicja E., et al.
Publicado: (2014)

Effects of Intronic and Exonic Polymorphisms of Paraoxonase 1 (PON1) Gene on Serum PON1 Activity in a Korean Population
por: Eom, Sang-Yong, et al.
Publicado: (2011)

Racial Differences in Paraoxonase-1 (PON1): A Factor in the Health of Southerners?
por: Davis, Kimberly A., et al.
Publicado: (2009)

Lead Exposure Is Associated with Decreased Serum Paraoxonase 1 (PON1) Activity and Genotypes
por: Li, Wan-Fen, et al.
Publicado: (2006)

Serial measurements of Paraoxonase-1 (PON-1) activity in horses with experimentally induced endotoxemia
por: Scavone, Donatella, et al.
Publicado: (2020)

O Gene da Paraoxonase 1 (PON1) no Contexto Doença Arterial Coronariana
por: Pinheiro, Denise da Silva, et al.
Publicado: (2022)

Role of paraoxonase 1 activity and PON1 gene polymorphisms in sickle cell disease
por: Menezes, Joelma Figueiredo, et al.
Publicado: (2023)

Association of Retinoid X Receptor Alpha Gene Polymorphism with Clinical Course of Chronic Glomerulonephritis
por: Grzegorzewska, Alicja E., et al.
Publicado: (2015)

Human Paraoxonase-2 (PON2): Protein Functions and Modulation
por: Manco, Giuseppe, et al.
Publicado: (2021)

The effect of paraoxonase 1 (PON1) gene polymorphisms T(-107)C and L55M and diet composition on serum PON1 activity in women
por: Zanini, Bianka Machado, et al.
Publicado: (2021)

Two common nonsynonymous paraoxonase 1 (PON1) gene polymorphisms and brain astrocytoma and meningioma
por: Martínez, Carmen, et al.
Publicado: (2010)

Reduced serum paraoxonase 1 (PON1) activity in patients with schizophrenia treated with olanzapine but not quetiapine
por: Ünsal, Cüneyt, et al.
Publicado: (2013)

Sex Difference Impacts on the Relationship between Paraoxonase-1 (PON1) and Type 2 Diabetes
por: Rosta, Valentina, et al.
Publicado: (2020)

Influence of nutritional factors and the PON1 C(-107)T polymorphism on paraoxonase-1 activity in childhood()
por: Sigales, Tainá S., et al.
Publicado: (2019)

DNMT1, DNMT3A and DNMT3B gene variants in relation to ovarian cancer risk in the Polish population
por: Mostowska, Adrianna, et al.
Publicado: (2013)

Paraoxonase (PON)-1: a brief overview on genetics, structure, polymorphisms and clinical relevance
por: Shunmoogam, Nelusha, et al.
Publicado: (2018)

Risk of Brain Tumors in Children and Susceptibility to Organophosphorus Insecticides: The Potential Role of Paraoxonase (PON1)
por: Nielsen, Susan Searles, et al.
Publicado: (2005)

Association analysis of PON2 genetic variants with serum paraoxonase activity and systemic lupus erythematosus
por: Dasgupta, Sudeshna, et al.
Publicado: (2011)

Paraoxonase 1 (PON1) Polymorphisms, Haplotypes and Activity in Predicting CAD Risk in North-West Indian Punjabis
por: Gupta, Nidhi, et al.
Publicado: (2011)

Age-Dependent Paraoxonase 1 (PON1) Activity and LDL Oxidation in Wistar Rats during Their Entire Lifespan
por: Kumar, Dileep, et al.
Publicado: (2014)

Genotype and phenotype of salt-stimulated paraoxonase 1 (PON1) is associated with atherogenic indices in type 2 diabetes
por: Qujeq, Durdi, et al.
Publicado: (2018)

Ticagrelor induces paraoxonase-1 (PON1) and better protects hypercholesterolemic mice against atherosclerosis compared to clopidogrel
por: Halim, Hasseri, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ejkntd45mbh3kjsim41adm5b1k